Impact of estrogen receptor expression level on response to neoadjuvant chemotherapy and prognosis in HER2-negative breast cancers
Abstract Background Breast cancers with 1–10% cell staining for estrogen receptor (ER) present particular clinical features. The clinical data of estrogen receptor expression level and treatment effect are limited, particularly regarding chemotherapy benefit. We evaluated the pathologic response to...
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artikulua |
| Hizkuntza: | English |
| Argitaratua: |
BMC
2023-09-01
|
| Saila: | BMC Cancer |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1186/s12885-023-11368-2 |